WHO Warns of Falsified Copies of Botulinum Toxin Product

September 1, 2022

Falsified copies of Ipsen’s Dysport – an injectable product used to treat cervical dystonia and spasticity as well as wrinkles – have been found in the UK, Poland, Türkiye, Kuwait and Jordan, according to a World Health Organization alert.

Dysport and other botulinum toxin products like AbbVie’s Botox are a target for counterfeiters, and are considered to pose a particularly high risk to the public as they are administered by intramuscular injection, so could cause serious infections if not produced in sterile conditions as well as other potential side effects.

The WHO notes that Ipsen has confirmed that all of the products covered in its alert are falsified “on the basis that they deliberately/fraudulently misrepresent their identity and source.”

It reports that the batch numbers and manufacturing expiry dates on the packaging are forged, and there are discrepancies in the packaging languages, printing errors on cartons, and the types of vial used, which reveal they are fake.

Read more at Securing Industry >>

Read the WHO Product Alert >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association